Medexus Pharmaceuticals Community
TSX:MDP Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 9 Fair Values set on narratives written by author
Community Investing Ideas
AN
Consensus Narrative from 7 Analysts
US Launch Of GRAFAPEX Will Provide Seven Years Of Exclusive Market Access
Key Takeaways FDA exclusivity for GRAFAPEX boosts revenue stability and reduces competitive pressure, enhancing margins. Strategic investments from public offering support GRAFAPEX's commercialization and drive future earnings growth.
View narrativeCA$6.46
FV
55.4% undervalued intrinsic discount8.15%
Revenue growth p.a.
1users have liked this narrative
0users have commented on this narrative
8users have followed this narrative
about 22 hours ago author updated this narrative